Scroll down Day 2 programme. Linda is chairing the plenary session commencing at 16.25. This is the last session of the entire conference. So she will effectively be doing the concluding remarks.
And she is on the the Immunotherapy Advisory Board along with senior guys from Pfizer, GSK, and Merck.
Sort of elevates her to the position of accepted insider. Different from previously.